Regeneron Pharmaceuticals (REGN)
Net Income
$4.82B
TTM · Period ending: · USD
REGN Net Income
Latest reported$4.82Bperiod ending
Latest reported$4.82Bperiod ending
REGN Net Income (-$3.30M → $4.82B)
Annual net income
High-resolution chart · PNG
REGN net income history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income (USD) |
|---|---|
| 4,504,900,000 | |
| 4,412,600,000 | |
| 3,953,600,000 | |
| 4,338,400,000 | |
| 8,075,300,000 | |
| 3,513,200,000 | |
| 2,115,800,000 | |
| 2,444,400,000 | |
| 1,198,511,000 | |
| 895,522,000 | |
| 636,056,000 | |
| 348,074,000 | |
| 424,362,000 | |
| 750,269,000 | |
| -221,760,000 | |
| -104,468,000 | |
| -67,830,000 | |
| -82,710,000 | |
| -105,600,000 | |
| -102,337,000 | |
| -95,446,000 | |
| 41,699,000 | |
| -107,458,000 | |
| -124,377,000 | |
| -76,180,000 | |
| -23,215,000 | |
| -23,100,000 | |
| -8,600,000 | |
| -11,600,000 | |
| -32,400,000 | |
| -23,500,000 | |
| -30,700,000 | |
| -39,900,000 | |
| -19,100,000 | |
| -4,500,000 | |
| -3,300,000 |